BIST 30, 50 and 100 Indices to Receive 2026 Q4 Revisions

Q4 2026 revisions on the BIST 100 index could rearrange portfolio weights and create mild downward pressure in the short term. The current price is above the SMA20 but below the SMA50, indicating a weak trend. RSI is around 50, while MACD is negative, supporting short-term selling pressure. Although the net effect of the revisions is uncertain, market participants may expect a mild decline in the short term. Therefore, a slight downward direction is forecast for XU100 over a 1-3 day period.

The news of 2026 Q4 revisions for the BIST 30, 50, and 100 indices suggests possible changes in index components but does not indicate a clear direction. XU030 has risen 2.37% in the last 24 hours and closed at 16391, indicating short-term positive momentum. With an RSI of 56.5, it is in neutral territory and does not give an overbought/oversold signal. The MACD is negative but above the signal line, indicating weakening downward momentum. The price is above the SMA20 but trading close to the SMA50; since the impact of the revision news is uncertain, I foresee a neutral outlook in the short term.